{"schema_version":"secwatch.filing_event.v1","accession":"0001370053-23-000013","form_type":"8-K","ticker":"ANAB","cik":"0001370053","company_name":"ANAPTYSBIO, INC","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.651901+00:00","generated_at":"2026-06-19T17:45:21.559477+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AnaptysBio adopts amended bylaws to align with DGCL changes and universal proxy rules","bullets":["Board approved Second Amended and Restated Bylaws effective Feb 7, 2023; updates advance notice, proxy procedures, and exclusive forum clause.","Amendments conform to 2022 DGCL changes on adjournment, stockholder lists, and electronic notices; adds emergency bylaw provision.","Enhanced stockholder nomination requirements: limits nominees to board seats, mandates compliance with SEC Universal Proxy Rules (Rule 14a-19).","Exclusive forum clause designates federal district courts for Securities Act claims unless company consents otherwise."],"urls":{"canonical":"https://secwatch.observer/filing/0001370053-23-000013","json":"https://secwatch.observer/filing/0001370053-23-000013.json","markdown":"https://secwatch.observer/filing/0001370053-23-000013.md","text":"https://secwatch.observer/filing/0001370053-23-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000013/0001370053-23-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000013/anab-20230207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T17:45:21.559477+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"21594f2378108c06a27f17aa6a607e7a8478247d","claim":"ANAPTYSBIO, INC: Adoption of second amended and restated bylaws with changes related to universal proxy rules, DGCL amendments, advance notice provisions, emergency bylaws, and exclusive forum for Securities Act claims (effective 2023-02-07).","evidence_excerpt":"approved and adopted the Company’s second amended and restated bylaws","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1370053/000137005323000013/0001370053-23-000013-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-02-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}